Yanlin Lv

Yanlin Lv

Auto-generated profile, based on publicly available information

Yanlin Lv

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
YLYanlin Lv
Yanlin Lv
FLFeng Li
Feng Li
SWShuang Wang
Shuang Wang
GLGuihong Lu
Guihong Lu
WBWeier Bao
Weier Bao
Guanghui MaGuanghui Ma
Guanghui Ma
The aggregative instinct of platelets was exploited as a biomimetic strategy for synergistic combined therapy against cancer.

26 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJiaqi Meng
Jiaqi Meng
YLYanlin Lv
Yanlin Lv
WBWeier Bao
Weier Bao
ZMZihui Meng
Zihui Meng
SWShuang Wang
Shuang Wang
WWWei Wei
Wei Wei
The therapeutic efficacy of whole tumor cell vaccines (TCVs) is modest, which has delayed their translation into personalized immunotherapies in the clinic. Here, we develop a TCV platform based on photothermal nanoparticle-loaded tumor cells, which can be rationally applied to diverse tumor types to achieve on-demand boost of anti-tumor immune responses for inhibiting tumor growth. During the fabrication process, mild photothermal heating by near-infrared (NIR) laser irradiation induces the nanoparticle-bearing tumor cells to express heat shock proteins as endogenous adjuvants. After a single vaccination at the back of tumor-bearing mice, non-invasive NIR laser irradiation further induces mild hyperthermia at vaccination site, which promotes the recruitment, activation, and antigen presentation by dendritic cells. Using an indicator we term fluctuation of tumor growth rate, we determine appropriate irradiation regimens (including optimized irradiation intervals and times). This TCV platform enables on-demand NIR manipulation of immune responses, and we demonstrate potent therapeutic efficacy against six murine models that mimick a range of clinical scenarios, including a model based on humanized mice and patient-derived tumor xenografts.